Curis Lifesciences (NSE:CURIS) Inventories, Work In Process: ₹114.8 Mil (As of Mar. 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
30 GF Score
Price ₹99.80
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences Inventories, Work In Process?

Curis Lifesciences NSE:CURIS +0.40% 30 Inventories, Work In Process is ₹114.8 Mil as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Curis Lifesciences's work in process for the quarter that ended in Mar. 2026 was ₹114.8 Mil.

Curis Lifesciences Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Inventories, Work In Process Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
17.51 25.83 46.55 114.76

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process 17.51 25.83 46.55 114.76
NSE:CURIS
30GF Score
Curis Lifesciences Ltd NSE:CURIS
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹114.8 Mil mean?
Curis Lifesciences (NSE:CURIS) has a Inventories, Work In Process of ₹114.8 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' Inventories, Work In Process too high?
Curis Lifesciences' current Inventories, Work In Process is ₹114.8 Mil. Overall, Curis Lifesciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Inventories, Work In Process compare to ZTS and UTHR?
Curis Lifesciences' Inventories, Work In Process of ₹114.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current Inventories, Work In Process is ₹114.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Inventories, Work In Process of ₹114.8 Mil. The current Inventories, Work In Process is ₹114.8 Mil. Curis Lifesciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Inventories, Work In Process is ₹114.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
30GF Score

Get the complete analysis for NSE:CURIS

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹99.80
Price